{
    "root": "2faf514b-295b-cba8-e063-6394a90a04b3",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ondansetron",
    "value": "20250306",
    "ingredients": [
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "ONDANSETRON HYDROCHLORIDE",
            "code": "NMH84OZK2B"
        }
    ],
    "indications": "Ondansetron oral solution is indicated for the prevention of nausea and vomiting associated with:\n                  \n                     highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m\n   2\n                     \n                     initial and repeat courses of moderately emetogenic cancer chemotherapy\n                     radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen\n                  \n                  Ondansetron oral solution is also indicated for the prevention of postoperative nausea and/or vomiting.",
    "contraindications": "See full prescribing information for the recommended dosage in adults and pediatrics. (2) Patients with severe hepatic impairment: do not exceed a total daily dose of 8 mg. (2.2 , 8.6)",
    "warningsAndPrecautions": "Ondansetron oral solution, USP a clear, colorless to light yellow liquid with a characteristic strawberry odor, contains 5 mg of ondansetron hydrochloride dihydrate equivalent to 4 mg of ondansetron per 5 mL:\n   \n\t5 mL unit dose cups: 30 cups (3 x 10) NDC 60687-252-86\n  \n                  \n                  Store at 20º to 25ºC (68º to 77ºF); excursions permitted between15º to 30º C (59º to 86ºF) [see USP Controlled Room Temperature]. Protect from light.\n                  \n                     DO NOT USE IF SEAL IS BROKEN.",
    "adverseReactions": "Ondansetron is contraindicated in patients:\n                  \n                     known to have hypersensitivity (e.g., anaphylaxis) to ondansetron or any of the components of the formulation \n   [see \n    Adverse Reactions (6.2)]. \n   \n                     \n                     receiving concomitant apomorphine due to the risk of profound hypotension and loss of consciousness."
}